Immediate Impact
1 by Nobel laureates 58 standout
Citing Papers
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Colorectal cancer statistics, 2023
2023 Standout
Works of Emanuela Rabaiotti being referenced
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer
2006
Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Emanuela Rabaiotti | 395 | 229 | 277 | 282 | 62 | 866 | |
| Lonnie S. Burnett | 408 | 340 | 197 | 204 | 46 | 1.2k | |
| Peter Grant | 503 | 349 | 171 | 350 | 57 | 1.2k | |
| Aşkın Doğan | 224 | 247 | 142 | 342 | 53 | 913 | |
| Katina Robison | 440 | 342 | 148 | 256 | 71 | 1.1k | |
| Nadereh Behtash | 292 | 372 | 203 | 225 | 71 | 978 | |
| R. Dgani | 391 | 321 | 188 | 194 | 54 | 827 | |
| Frans J.M. Huikeshoven | 169 | 318 | 167 | 250 | 51 | 957 | |
| Iordanis Navrozoglou | 211 | 250 | 96 | 110 | 48 | 827 | |
| Gökhan Açmaz | 207 | 343 | 218 | 79 | 73 | 803 | |
| Tamar Perri | 603 | 472 | 278 | 181 | 62 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...